These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14716773)

  • 1. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma.
    Li CC; Tien HF; Tang JL; Yao M; Chen YC; Su IJ; Hsu SM; Hong RL
    Cancer; 2004 Jan; 100(2):366-75. PubMed ID: 14716773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
    Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
    Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
    Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
    Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.
    Koom WS; Chung EJ; Yang WI; Shim SJ; Suh CO; Roh JK; Yoon JH; Kim GE
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1127-37. PubMed ID: 15234048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].
    Yao B; Li YX; Fang H; Yu ZH; Jin J; Liu XF
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):222-5. PubMed ID: 16875550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters.
    Isobe K; Uno T; Tamaru J; Kawakami H; Ueno N; Wakita H; Okada J; Itami J; Ito H
    Cancer; 2006 Feb; 106(3):609-15. PubMed ID: 16369986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
    Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
    J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
    Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy.
    Tham IW; Lee KM; Yap SP; Loong SL
    Head Neck; 2006 Feb; 28(2):126-34. PubMed ID: 16240328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature.
    Go RS; Wester SM
    Cancer; 2004 Sep; 101(6):1404-13. PubMed ID: 15368328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases].
    Huang Y; Lin TY; Wu QL; Su ZL; Huang HQ; Xia ZJ; Sun XF; Jiang WQ; Guan ZZ
    Ai Zheng; 2005 Apr; 24(4):470-4. PubMed ID: 15820072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy.
    Li YX; Liu QF; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Liu XF; Zhou LQ; Yu ZH
    Cancer; 2011 Nov; 117(22):5203-11. PubMed ID: 21523771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.